Skip to content

Whole-course management on patients with intermediate and advanced-stage malignancies - A bidirectional cohort study

Whole-course management on patients with intermediate and advanced-stage malignancies - A bidirectional cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075430
Enrollment
Unknown
Registered
2023-09-05
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

Case series:N/A

Sponsors

Shaoxing Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Participants aged = 18 years. 2) Patients with a histopathological or clinical diagnosis of advanced malignant tumors. 3) Individuals who can fully comprehend the content of this study, have the ability to adhere to the follow-up plan, sign the informed consent form, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1) Age < 18 years. 2) Pathologically diagnosed as a benign tumor. 3) Tumor staging classified as early-stage. 4) Presence of cognitive impairment. 5) Patients who are unable to understand or comply with the study procedures and sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Patient reported outcomes;

Secondary

MeasureTime frame
Core symptom cluster;time to functional recovery;overall survival time;Follow-up completion rate;Progression Free Survival;Overall Response Rate;time to change of treatment regimens;Adverse event rate;

Countries

China

Contacts

Public ContactLi Tang

Shaoxing Second Hospital

15215993605@163.com+86 152 1599 3605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026